{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:58:51Z","timestamp":1778695131966,"version":"3.51.4"},"reference-count":17,"publisher":"American Association for Cancer Research (AACR)","issue":"8","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Epidemiologic studies have reported the underrepresentation of cervical precancerous lesions caused by human papillomavirus (HPV) types 18 and 45 (HPV18\/45) compared with the proportion of cervical cancers attributed to these HPV types. We investigated the timing of diagnosis of histologic cervical intraepithelial neoplasia grade 3 or worse (CIN3+) using data from the atypical squamous cells of undetermined significance\u2013low-grade squamous intraepithelial lesion triage study (ALTS). Of the 2,725 women who underwent enrollment colposcopy, 412 of 472 (87.3%) diagnosed with histologic CIN3+ over the 2-year duration of ALTS could be assigned to a HPV type or group of types and were included in this analysis. Eighty-four percent of HPV16-positive CIN3+ were diagnosed at enrollment, compared with 57% of HPV18\/45-positive CIN3+, and 58% of CIN3 positive for other carcinogenic HPV types at enrollment. In contrast, only 8% of HPV16-positive CIN3+ were diagnosed at exit, whereas 31% were HPV18\/45 positive and 22% were positive for other carcinogenic types at study exit (P &amp;lt; 0.001). These results indicate the underrepresentation of HPV18\/45 in precancers, whereas HPV16-associated CIN3+ is diagnosed much earlier. Whether the underrepresentation of 18\/45 may be due to occult pathology needs further investigation. [Cancer Res 2009;69(8):3262\u20136]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-4192","type":"journal-article","created":{"date-parts":[[2009,4,8]],"date-time":"2009-04-08T02:38:58Z","timestamp":1239158338000},"page":"3262-3266","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Detection of Precancerous Cervical Lesions Is Differential by Human Papillomavirus Type"],"prefix":"10.1158","volume":"69","author":[{"given":"Mahboobeh","family":"Safaeian","sequence":"first","affiliation":[{"name":"1Cancer Epidemiology and Genetics and Divisions of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[{"name":"1Cancer Epidemiology and Genetics and Divisions of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Gage","sequence":"additional","affiliation":[{"name":"1Cancer Epidemiology and Genetics and Divisions of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Solomon","sequence":"additional","affiliation":[{"name":"2Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosette M.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"3Departments of Molecular Genetics and Microbiology and Obstetrics and Gynecology, University of New Mexico Health Sciences Center, School of Medicine, Albuquerque, New Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip E.","family":"Castle","sequence":"additional","affiliation":[{"name":"1Cancer Epidemiology and Genetics and Divisions of"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2009,4,15]]},"reference":[{"key":"2022061701485505900_B1","doi-asserted-by":"crossref","unstructured":"Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer\u20082003; 89: 101\u20135.","DOI":"10.1038\/sj.bjc.6601024"},{"key":"2022061701485505900_B2","doi-asserted-by":"crossref","unstructured":"Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer\u20082003; 88: 63\u201373.","DOI":"10.1038\/sj.bjc.6600688"},{"key":"2022061701485505900_B3","doi-asserted-by":"crossref","unstructured":"Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer\u20082007; 121: 621\u201332.","DOI":"10.1002\/ijc.22527"},{"key":"2022061701485505900_B4","doi-asserted-by":"crossref","unstructured":"Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst\u20082005; 97: 1072\u20139.","DOI":"10.1093\/jnci\/dji187"},{"key":"2022061701485505900_B5","doi-asserted-by":"crossref","unstructured":"Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol\u20081992; 79: 328\u201337.","DOI":"10.1097\/00006250-199203000-00002"},{"key":"2022061701485505900_B6","doi-asserted-by":"crossref","unstructured":"Kovacic MB, Castle PE, Herrero R, et al. Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res\u20082006; 66: 10112\u20139.","DOI":"10.1158\/0008-5472.CAN-06-1812"},{"key":"2022061701485505900_B7","doi-asserted-by":"crossref","unstructured":"Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology\u20082005; 337: 76\u201384.","DOI":"10.1016\/j.virol.2005.04.002"},{"key":"2022061701485505900_B8","doi-asserted-by":"crossref","unstructured":"Schiffman M, Adrianza ME. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol\u20082000; 44: 726\u201342.","DOI":"10.1159\/000328554"},{"key":"2022061701485505900_B9","doi-asserted-by":"crossref","unstructured":"Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance\/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst\u20082000; 92: 397\u2013402.","DOI":"10.1093\/jnci\/92.5.397"},{"key":"2022061701485505900_B10","doi-asserted-by":"crossref","unstructured":"ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol\u20082003; 188: 1393\u2013400.","DOI":"10.1016\/S0002-9378(03)00413-7"},{"key":"2022061701485505900_B11","doi-asserted-by":"crossref","unstructured":"ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol\u20082003; 188: 1383\u201392.","DOI":"10.1016\/S0002-9378(03)00418-6"},{"key":"2022061701485505900_B12","doi-asserted-by":"crossref","unstructured":"Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst\u20082001; 93: 293\u20139.","DOI":"10.1093\/jnci\/93.4.293"},{"key":"2022061701485505900_B13","doi-asserted-by":"crossref","unstructured":"Gage JC, Hanson VW, Abbey K, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol\u20082006; 108: 264\u201372.","DOI":"10.1097\/01.AOG.0000220505.18525.85"},{"key":"2022061701485505900_B14","doi-asserted-by":"crossref","unstructured":"Castle PE, Cox JT, Jeronimo J, et al. An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS). Obstet Gynecol\u20082008; 111: 847\u201356.","DOI":"10.1097\/AOG.0b013e318168460b"},{"key":"2022061701485505900_B15","doi-asserted-by":"crossref","unstructured":"Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol\u20082000; 38: 357\u201361.","DOI":"10.1128\/JCM.38.1.357-361.2000"},{"key":"2022061701485505900_B16","doi-asserted-by":"crossref","unstructured":"Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis\u20082001; 183: 1554\u201364.","DOI":"10.1086\/320696"},{"key":"2022061701485505900_B17","doi-asserted-by":"crossref","unstructured":"Jeronimo J, Massad LS, Schiffman M. Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type. Am J Obstet Gynecol\u20082007; 197: 47\u20138.","DOI":"10.1016\/j.ajog.2007.02.047"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/8\/3262\/2623780\/3262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/8\/3262\/2623780\/3262.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T09:19:38Z","timestamp":1655457578000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/8\/3262\/553321\/Detection-of-Precancerous-Cervical-Lesions-Is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,15]]},"references-count":17,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2009,4,15]]},"published-print":{"date-parts":[[2009,4,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-4192","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,15]]}}}